Author

C. Hansel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Artzy-Schnirman· 1 shared B. Porebski· 1 shared D. Huhn· 1 shared E. Abu-Shah· 1 shared E. Altman· 1 shared J. Carreras-Puigvert· 1 shared J. Ramos· 1 shared K. Tschapalda· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Artzy-Schnirman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Artificial Antigen Presenting Cells for Detection and Desensitisation of Auto-reactive T cells Associated with Type 1 Diabetes

A. Artzy-Schnirman, E. Abu-Shah, R. Chandrawati, E. Altman, N. Yusuf, S.-T. Wang, J. Ramos, C. Hansel, M. Haus-cohen, R. Dahan, S. Arif, M. L. Dustin, M. Peakman, Y. Reiter, M. M. Stevens

This paper develops artificial antigen presenting cells (aAPCs) to detect and desensitize autoreactive T cells in type 1 diabetes, showing effectiveness in human and mouse models.

bioRxiv · Dec 26, 2020 · PreprintBioengineering

Estrogen deprivation triggers an immunosuppressive phenotype in breast cancer cells

D. Huhn, P. Marti-Rodrigo, S. Mouron, C. Hansel, K. Tschapalda, B. Porebski, M. Haggblad, L. Lidemalm, M. A. Quintela-Fandino, J. Carreras-Puigvert, O. Fernandez-Capetillo

This study shows that estrogen deprivation in ER-positive breast cancer cells increases PD-L1 expression and triggers an immunosuppressive program, leading to resistance against T-cell killing.

bioRxiv · Aug 28, 2019 · PreprintCancer Biology